462
Views
3
CrossRef citations to date
0
Altmetric
Clinical features - Original Research

Effects of a pharmacist-managed anticoagulation outpatient clinic in Taiwan: evaluation of patient knowledge, satisfaction, and clinical outcomes

ORCID Icon, , ORCID Icon, , , , , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 964-973 | Received 10 Apr 2021, Accepted 25 Jun 2021, Published online: 19 Aug 2021

References

  • Baumgartner H, Falk V, Bax JJ, et al. ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–2791.
  • Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42(5):373–498.
  • January CT, Wann LS, Calkins H, et al. AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: a report of the American college of cardiology/American Heart association task force on clinical practice guidelines and the heart rhythm society in collaboration with the society of thoracic surgeons. Circulation. 2019;140(2):e125–e151.
  • Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the american college of cardiology/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2021;77(4):450–500.
  • Ansell J, Hirsh J, Hylek E, et al. Pharmacology and management of the vitamin K antagonists: american college of chest physicians evidence-based clinical practice guidelines. Chest. 2008;133(6):160S–198S.
  • Vallakati A, Lewis WR. Underuse of anticoagulation in patients with atrial fibrillation. Postgrad Med. 2016;128(2):191–200.
  • Carpenter M, Berry H, Pelletier AL. Clinically relevant drug-drug interactions in primary care. Am Fam Physician. 2019;99(9):558–564.
  • Witt DM, Sadler MA, Shanahan RL, et al. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest. 2005;127(5):1515–1522.
  • Hou K, Yang H, Ye Z, et al. Effectiveness of pharmacist-led anticoagulation management on clinical outcomes: a systematic review and meta-analysis. J Pharm Pharm Sci. 2017;20(1):378–396.
  • Clarkesmith DE, Pattison HM, Lip GY, et al. Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial. PLoS One. 2013;8(9):e74037.
  • Chen YC, Fan JS, Chen MH, et al. Risk factors associated with adverse drug events among older adults in emergency department. Eur J Intern Med. 2014;25(1):49–55.
  • Hsu WT, Shen LJ, Lee CM. Drug-related problems vary with medication category and treatment duration in Taiwanese heart failure outpatients receiving case management. J Formos Med Assoc. 2016;115(5):335–342.
  • Martin J. Self-regulated learning, social cognitive theory, and agency. Educ Psychol. 2004;39(2):135–145.
  • Huang YM, Pecanac KE, Shiyanbola OO. “Why am I not taking medications?” Barriers and facilitators of diabetes medication adherence across different health literacy levels. Qual Health Res. 2020;30(14):2331–2342.
  • Rickles N, Svarstad B. The patient: behavioral determinants. Remington: the science and practice of pharmacy, 22nd ed; Allen, L, Ed. 2012:1893–1902.
  • Faul F, Erdfelder E, Buchner A, et al. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149–1160.
  • Cohen J. Statistical power analysis for the behavioral sciences. Academic Press; 2013.
  • Barcellona D, Contu P, Marongiu F. Patient education and oral anticoagulant therapy. Haematologica. 2002;87(10):1081–1086.
  • Tang EOYL, Lai CS, Lee KK, et al. Relationship between patients’ warfarin knowledge and anticoagulation control. Ann Pharmacother. 2003;37(1):34–39.
  • Willey ML, Chagan L, Sisca TS, et al. A pharmacist-managed anticoagulation clinic: six-year assessment of patient outcomes. Am J Health Syst Pharm. 2003;60(10):1033–1037.
  • Davis NJ, Billett HH, Cohen HW, et al. Impact of adherence, knowledge, and quality of life on anticoagulation control. Ann Pharmacother. 2005;39(4):632–636.
  • Haynes SN, Richard D, Kubany ES. Content validity in psychological assessment: a functional approach to concepts and methods. Psychol Assess. 1995;7(3):238–247.
  • Kuo LN, Liou JP, Chen HY, et al. Evaluation of the safety and efficacy of warfarin in Taiwanese patients. Int J Clin Pharmacol Ther. 2013;51(2):106–113.
  • Lip GY, Wang KL, Chiang CE. Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: time for a reappraisal. Int J Cardiol. 2015;180:246–254.
  • Chiang CE, Wang KL, Lin SJ. Asian strategy for stroke prevention in atrial fibrillation. Europace. 2016;17(suppl_2):ii31–ii39.
  • Camm AJ, Lip GY, De Caterina R, et al. focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation developed with the special contribution of the European heart rhythm association. Eur Heart J. 2012;33(21):2719–2747.
  • Sconce E, Khan T, Mason J, et al. Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation. Thromb Haemost. 2005;93(5):872–875.
  • Sconce E, Avery P, Wynne H, et al. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood. 2007;109(6):2419–2423.
  • Huang YM, Yang YH, Lin SJ, et al. Medication knowledge to be improved in participants in community universities in Taiwan: outcome of a nationwide community university program. J Formos Med Assoc. 2015;114(12):1267–1279.
  • Huang YM, Wang HP, Yang YH, et al. Effects of a national health education program on the medication knowledge of the public in Taiwan. Ann Pharmacother. 2006;40(1):102–108.
  • Wang Y, Kong MC, Lee LH, et al. Knowledge, satisfaction, and concerns regarding warfarin therapy and their association with warfarin adherence and anticoagulation control. Thromb Res. 2014;133(4):550–554.
  • Atreja A, Bellam N, Levy SR. Strategies to enhance patient adherence: making it simple. MedGenMed. 2005;7(1):4.
  • Registry Investigators J-RHYTHM. Determinants of warfarin use and international normalized ratio levels in atrial fibrillation patients in Japan. Circ J. 2011;75(10):2357–2362.
  • Pokorney SD, Simon DN, Thomas L, et al. Patients’ time in therapeutic range on warfarin among US patients with atrial fibrillation: results from ORBIT-AF registry. Am Heart J. 2015;170(1):141–148.
  • Clarkesmith DE, Pattison HM, Khaing PH, et al. Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation. Cochrane Database Syst Rev. 2017;4(4):CD008600.
  • Shiyanbola OO, Unni E, Huang YM, et al. Using the extended self-regulatory model to characterise diabetes medication adherence: a cross-sectional study. BMJ Open. 2018;8(11):e022803.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.